T. Ulven, P. H. J. Carlsen
FULL PAPER
6.2 Hz, 3 H, Me), 1.86 (d, J ϭ 5.2 Hz, 1 H, OH), 2.43Ϫ2.53 (m, 1
Ϫ MS: m/z (% rel.int.) ϭ 222 (13) [Mϩ], 221 (10), 150 (6), 149 (8),
H, H-1Ј), 2.59Ϫ2.69 (m, 1 H, H-1Ј), 3.23 (td, J ϭ 9.0, 5.1 Hz, 1 H, 108 (8), 107 (100), 106 (28), 105 (57), 91 (9), 79 (22), 77 (35).
H-5), 3.65 (ddd, J ϭ 9.1, 6.8, 4.4 Hz, 1 H, H-4), 3.69 (dq, J ϭ 9.0,
3,5-O-Benzylidene-2-deoxy-D-threo-pentofuranose (26): Preparation
6.2 Hz, 1 H, H-6), 5.15 (dm, J ϭ 10.2 Hz, 1 H, H-(E)-3Ј), 5.22 (dm,
J ϭ 17.3 Hz, 1 H, H-(Z)-3Ј), 5.58 (s, 1 H, H-2), 6.03 (ddt*, J ϭ
17.2, 10.2, 7.1 Hz, 1 H, H-2), 7.34Ϫ7.42 (m, 3 H, Ph), 7.48Ϫ7.54
(m, 2 H, Ph). Ϫ NOE experiments: irr. at OH Ǟ NOE at H-5 and
H-4/H-6; irr. at Me Ǟ NOE at H-4; irr. at H-2 Ǟ NOE at H-4/H-
6 and Ph; irr. at H-5 Ǟ no NOE. Ϫ 13C NMR (300 MHz, CDCl3):
δ ϭ 18.2 (Me), 36.9 (H-1Ј), 72.1 (H-5), 77.4 (H-4/H-6), 80.4 (H-4/
H-6), 100.6 (H-2), 117.7 (H-3Ј), 126.4 (Ph), 128.4 (Ph), 129.0 (Ph),
from 25 (57 mg, 0.26 mmol) according to the general procedure
VII. Purification by flash chromatography (SiO2, Et2O/cyclohex-
ane, 1:1, then EtOAc) gave another 51 mg (89%) 26 as a crystalline
solid. Ϫ [α]2D0 ϭ ϩ7 changing to Ϫ32 (equilibrium) (c ϭ 1.0,
CHCl3). Ϫ 1H and 13C NMR showed the crystals to consist of
essentially pure α-anomer, and the β-anomer to be in excess in an
approximately 2:1 anomeric mixture at equilibrium in CDCl3. The
1
α-Anomer (Crystalline): M.p. 135Ϫ136 °C. Ϫ H NMR (300 MHz,
˜
134.6 (H-2), 138.1 (Ph). Ϫ IR (neat): ν ϭ 3466 (broad), 3072, 2977,
CDCl3): δ ϭ 2.10 (dt, J ϭ 14.6, 4.7 Hz, 1 H, H-2), 2.50 (dd, J ϭ
14.6, 5.7 Hz, 1 H, H-2), 3.09 (d, J ϭ 3.1 Hz, 1 H, OH), 4.07 (td,
J ϭ 2.2, 1.1 Hz, 1 H, H-4), 4.17 (dd, J ϭ 13.2, 2.2 Hz, 1 H, H-5),
4.44 (d, J ϭ 13.2 Hz, 1 H, H-5), 4.56 (dd, J ϭ 5.0, 2.3 Hz, 1 H, H-
3), 5.45 (s, 1 H, acetal), 5.88 (m, 1 H, H-1), 7.32Ϫ7.40 (m, 3 H,
Ph), 7.46Ϫ7.50 (m, 2 H, Ph). Ϫ NOE experiments: irr. at H-1 Ǟ
NOE at OH and H-2α; irr. at H-2α Ǟ NOE at H-2β and H-1; irr.
at H-2β Ǟ NOE at H-2α, H-4, and H-3. Ϫ 13C NMR (300 MHz,
CDCl3): δ ϭ 42.2 (C-2), 67.1 (C-5),72.8 (C-4), 76.1 (C-3), 98.9 (C-
1), 99.4 (acetal), 126.1 (Ph), 128. 3 (Ph), 129.0 (Ph), 137.8 (Ph). Ϫ
IR (KBr): ν˜ ϭ 3392 (broad), 3059, 2976, 2914, 1448, 1397, 1369,
1328, 1253, 1134, 1069, 1025, 992, 826, 743, 697 cmϪ1. Ϫ MS: m/
z (% rel.int.) ϭ 222 (3) [Mϩ], 221 (11), 176 (2), 175 (5), 150 (2),
149 (3), 108 (7), 107 (81), 106 (51), 105 (100), 91 (14), 81 (16), 79
(41), 78 (20), 77 (97). The β-Anomer (Major Anomer at Equilibrium
2856, 1409, 1091, 1050, 1029, 756, 698 cmϪ1. Ϫ MS: m/z (% rel.
int.) ϭ 235 (0.5), 234 (5) [Mϩ], 233 (5), 207 (2), 194 (3), 193 (22),
164 (8), 108 (9), 107 (100), 105 (20), 84 (20), 79 (19), 77 (17). Ϫ
C13H18O3: calcd. C 71.77, H 7.74; found C 70.75, H 7.81.
(2R,4S,5R,6R)-(؊)-4-Allyl-6-methyl-2-phenyl-1,3-dioxan-5-ol (21):
Reduction of 20 (255 mg, 1.1 mmol) according to the general pro-
cedure VI yielded the crude product as 266 mg of a pale yellow oil
(77% pure by GC), consisting of 21 and 17 in 19:1 ratio (deter-
1
mined by H NMR). Purification by flash chromatography (SiO2,
Et2O/cyclohexane, 1:2) afforded 174 mg (68%) of 21: M.p. 40Ϫ43
1
°C(not recrystallized). Ϫ [α]2D0 ϭ Ϫ30 (c ϭ 1, CHCl3). Ϫ H NMR
(300 MHz, CDCl3): δ ϭ 1.38 (d, J ϭ 6.4 Hz, 3 H, Me), 1.70 (d,
J ϭ 11.8 Hz, 1 H, OH), 2.45 (s, 1 H), 2.49Ϫ2.56 (m, 2 H, 2 H-1Ј),
3.32 (d, J ϭ 11.4 Hz, 1 H, H-5), 3.87 (td, J ϭ 7.1, 0.9 Hz, 1 H, H-
4), 4.01 (qd, J ϭ 6.4, 1.0 Hz, 1 H, H-6), 5.14 [dm, J ϭ 10.1 Hz, 1
H, H-(E)-3Ј], 5.22 [dm, J ϭ 17.1 Hz, 1 H, H-(Z)-3Ј], 5.61 (s, 1 H,
H-2), 5.89 (ddt*, J ϭ 17.1, 10.0, 7.1 Hz, 1 H, H-2Ј), 7.34Ϫ7.44 (m,
3 H, Ph), 7.50Ϫ7.55 (m, 2 H, Ph). Ϫ NOE experiments: irr. at H-
2 Ǟ NOE at H-4 and H-6; irr. at H-6 Ǟ NOE at H-2 and Me; irr.
at H-4 Ǟ NOE at H-2; irr. at H-5 Ǟ NOE at H-4, H-6 and Me;
irr at OH Ǟ No NOE; irr. at Me Ǟ NOE at H-6. Ϫ 13C NMR
(300 MHz, CDCl3): δ ϭ 17.6 (Me), 36.0 (C-1Ј), 67.8 (C-5), 77.2 (C-
6), 80.8 (C-4), 101.6 (C-2), 118.3 (C-3Ј), 126.4 (Ph), 128.7 (Ph),
1
in CDCl3): H NMR (300 MHz, CDCl3): δ ϭ 2.16Ϫ2.31 (m, 2 H,
2 H-2), 3.82 (s, 1 H, OH), 3.85 (d, J ϭ 12.6 Hz, 1 H, H-4), 4.16
(dm, J 13 Hz, 1 H, H-5), 4.52 (d, J ϭ 13.5 Hz, 1 H, H-5), 4.58
(m, 1 H, H-3), 5.48 (s, 1 H, acetal), 5.49 (m, 1 H, H-1), 7.32Ϫ7.40
(m, 3 H, Ph), 7.46Ϫ7.50 (m, 2 H, Ph). Ϫ 13C NMR (300 MHz,
CDCl3): δ ϭ 41.7 (C-2), 67.9 (C-5), 74.8 (C-4), 77.3 (C-3), 99.7
(acetal), 99.8 (C-1), 126.0 (Ph), 128.5 (Ph), 129.3 (Ph), 137.5 (Ph).
(؉)-3,5-O-Benzylidene-2,6-dideoxy-D-lyxo-hexoaldose (13): Pre-
paration from 9 (164 mg, 0.70 mmol) as described by the general
procedure VII. The crude product was purified by flash chromato-
graphy (SiO2, EtOAc/cyclohexane, 1:1) to give (ϩ)-13 (151 mg,
91%) as a colorless syrup. [α]2D0 ϭ ϩ58 (c ϭ 1.0, CHCl3). Ϫ
1H NMR (300 MHz, CDCl3): δ ϭ 1.49 (d, J ϭ 7.0 Hz, 3 H, H-6),
2.38 (m, 1 H, OH), 2.79 (ddd, J ϭ 16.8, 7.0, 2.1 Hz, 1 H, H-2),
2.90 (ddd, J ϭ 16.8, 4.9, 1.5 Hz, 1 H, H-2), 3.86 (m, 1 H, H-4),
4.36Ϫ4.50 (m, 2 H, H-3 and H-5), 5.87 (s, 1 H, acetal), 7.35Ϫ7.41
(m, 3 H, Ph), 7.44Ϫ7.48 (m, 2 H, Ph), 9.85 (t, J ϭ 1.7 Hz, 1 H, H-
1). Ϫ 13C NMR (300 MHz, CDCl3): 11.4 (C-6), 46.9 (C-2), 68.7
(C-4), 71.2 (C-4/C-6), 72.3 (C-6/C-4), 93.9 (acetal), 126.3 (Ph),
128.5 (Ph), 129.2 (Ph), 137.9 (Ph), 201.2 (C-1). Ϫ IR (neat): ν˜ ϭ
3445 (broad), 1723, 1095, 1077 cmϪ1. Ϫ MS: m/z (% rel.int.) ϭ 237
(1), 236 (4) [Mϩ], 235 (6), 174 (3), 163 (5), 151 (2), 133 (2), 123 (2),
113 (2), 108 (9), 107 (100), 106 (26), 105 (41), 86 (57), 79 (20), 77
(36). Ϫ C13H16O4: calcd. C 66.09, H 6.83, O 27.09; found C 65.80,
H 8.13, O 26.07.
˜
129.4 (Ph), 134.0 (C-2Ј), 138.4 (Ph). Ϫ IR (neat): ν ϭ 3306 (broad),
3070, 2982, 2863, 1641, 1403, 1337, 1172, 1098, 1069, 1028, 999,
749, 699 cmϪ1. Ϫ MS: m/z (% rel.int.) ϭ 220 (2) [Mϩ], 219 (7), 189
(1), 179 (17), 177 (3), 150 (6), 149 (5), 108 (7), 107 (100), 105 (40),
91 (22), 79 (58), 78 (10), 77 (45).
General Procedure VII. ؊ Ozonolysis: Through a solution of the
alkene (1.0 mmol) in MeOH (30 mL) at Ϫ78 °C was passed a
stream of ozone, until a persistent blue color appeared. The solu-
tion was flushed with N2 until no more ozone was detected. After
30 min, Me2S (0.7 mL) was added and the solution was allowed to
slowly reach room temperature and stirred overnight. Concentra-
tion under reduced pressure gave the crude product, which was
purified by flash-chromatography or crystallization.
3,5-O-Benzylidene-2-deoxy-DL-erythro-pentoaldose (26): Prepara-
tion from racemic 25 (55 mg, 0.25 mmol) as described in the gen-
eral procedure VII. Purification of the crude product by flash chro-
(؉)-3,5-O-Benzylidene-2,6-dideoxy-
D-arabino-hexofuranose
(15):
matography (SiO2, Et2O/cyclohexane, 1:1; then EtOAc) gave 26 as
a colorless oil (53 mg, 95%). Ϫ H NMR (300 MHz, CDCl3): δ ϭ eral procedure VII. Purification of the crude product by flash chro-
2.34 (d, J ϭ 5.4 Hz, 1 H, OH), 2.86 (ddd, J ϭ 16.9, 6.9, 2.1 Hz, 1 matography (SiO2, EtOAc/cyclohexane, 1:1) yielded an anomeric
Preparation from 10 (107 mg, 0.46 mmol) as described by the gen-
1
H, H-2), 2.94 (ddd, J ϭ 16.9, 5.1, 1.6 Hz, 1 H, H-2), 3.58Ϫ3.71
mixture of 15 (101 mg, 94%) as a colorless oil. [α]2D0 ϭ ؉48 (c ϭ
(m, 2 H), 4.12 (ddd, J ϭ 8.7, 6.9, 5.1, 1 H, H-3), 4.30 (m, 1 H, H- 1.2, CHCl3). Major Anomer: 1H NMR (300 MHz, CDCl3): δ ϭ
5), 5.52 (s, 1 H, benzylidene), 7.33Ϫ7.40 (m, 3 H, Ph), 7.42Ϫ7.49
1.44 (d, J ϭ 6.2 Hz, 3 H, H-6), 2.12Ϫ2.21 (m, 1 H, H-2), 2.33Ϫ2.43
(m, 2 H, Ph), 9.85 (t, J ϭ 1.9, 1 H, H-1). Ϫ 13C NMR (400 MHz, (m, 1 H, H-2), 3.03 (dd, J ϭ 3.3, 1.0 Hz, 1 H, OH), 3.81 (dq, J ϭ
CDCl3): δ ϭ 46.5 (C-2), 65.4, 71.4, 77.0, 101.0 (benzylidene), 126.0 7.8, 6.3 Hz, 1 H, H-5), 4.06 (dd, J ϭ 7.9, 5.8 Hz, 1 H, H-4), 4.71
(Ph), 128.2 (Ph), 129.0 (Ph), 137.2 (Ph), 200.8 (C-1). Ϫ IR (neat):
(dt, J ϭ 7.1, 6.0 Hz, 1 H, H-3), 5.68 (ddd, J ϭ 5.3, 3.3, 2.0 Hz, 1
H, H-1), 5.85 (s, 1 H, acetal), 7.32Ϫ7.45 (m, 3 H, Ph), 7.46Ϫ7.55
3448 (broad), 2858, 1723, 1455, 1397, 1076, 1026, 757, 699 cmϪ1
.
3372
Eur. J. Org. Chem. 2001, 3367Ϫ3374